Glenmark Pharmaceuticals Has Received Final Approval From The US Health - Dollar Advisory Financial Services

Breaking

Friday 20 April 2018

Glenmark Pharmaceuticals Has Received Final Approval From The US Health

Glenmark Pharmaceuticals has received final approval from the US health regulator for a generic version of Temovate Topical Solution used to treat certain scalp and skin conditions.

Glenmark Pharmaceuticals USA has been granted final approval by the US Food and Drug Administration for Clobetasol Propionate Topical Solution USP, 0.05%, the company said in a BSE filing.

The approved product is the generic version of Temovate Topical Solution.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory

No comments:

Post a Comment